Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04988321 · ClinicalTrials.gov registry record · NA
Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT04988321 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 49 participants.
The verdict
NCT04988321, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the effects of a newer form of non-invasive brain stimulation (called transcranial magnetic stimulation or TMS) as a treatment in patients with painful diabetic neuropathy to examine its effects on their understanding of their pain experience.
Interventions
- PROCEDURE Prolonged continuous theta burst stimulation (pcTBS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2021-09-03 |
| Est. Completion | 2022-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04988321
The ClinicalTrials.gov registry entry for NCT04988321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prolonged continuous theta burst stimulation (pcTBS) is the first listed.
NCT04988321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04988321 about?
NCT04988321 is a clinical study titled "Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms". The purpose of the study is to determine the effects of a newer form of non-invasive brain stimulation (called transcranial magnetic stimulation or TMS) as a treatment in patients with painful diabetic neuropathy to examine its effects on their understanding of their pain experience.
What is the current status of trial NCT04988321?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2021-09-03. Estimated completion is 2022-06-16.
What interventions are being tested in trial NCT04988321?
The interventions under investigation include: Prolonged continuous theta burst stimulation (pcTBS) (PROCEDURE).
Who is sponsoring clinical trial NCT04988321?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.